We are live on ! Find out more
PIM

Ponoi II Management Portfolio holdings

AUM $38.3M
1-Year Est. Return 32.02%
This Fund
S&P 500
This Quarter Est. Return
+4.54%
1 Year Est. Return
-32.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$38.3M
AUM Growth
+$1.46M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$17M 44.41%
1,298,908
RVMD icon
2
Revolution Medicines
RVMD
$38.1B
$13.5M 35.31%
685,011
NRIX icon
3
Nurix Therapeutics
NRIX
$2.39B
$4.26M 11.14%
327,123
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
$3.5M 9.14%
18,175

Similar funds

Ponoi II Management's Q3 2022 Portfolio in Review

As of Q3 2022, Ponoi II Management held 4 positions worth $38.3M, up 4% from $36.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Ponoi II Management opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Ponoi II Management's ten largest holdings make up 100% of its $38.3M portfolio in Q3 2022.
  • Ponoi II Management opened 0 new positions and closed 0 in Q3 2022.
  • Ponoi II Management's portfolio value rose 4% quarter-over-quarter to $38.3M.

Based on Ponoi II Management's 13F filing for Q3 2022, filed 14 Nov 2022.